Table 3. Distribution of GBS isolates according to ST-type and serotype.
| ST type | Serotype III | Serotype IV | Serotype VI | Serotype 1b | Serotype 1a | Total |
|---|---|---|---|---|---|---|
| ST1 | 1 | 0 | 20 | 0 | 0 | 21 |
| ST4 | 0 | 0 | 0 | 1 | 0 | 1 |
| ST6 | 0 | 0 | 0 | 1 | 0 | 1 |
| ST8 | 0 | 0 | 4 | 0 | 0 | 4 |
| ST12 | 1 | 0 | 0 | 0 | 0 | 1 |
| ST17 | 21 | 0 | 2 | 0 | 1 | 24 |
| ST19 | 4 | 0 | 1 | 0 | 0 | 5 |
| ST23 | 1 | 0 | 0 | 0 | 0 | 1 |
| ST27 | 2 | 0 | 1 | 0 | 0 | 3 |
| ST196 | 0 | 0 | 1 | 0 | 0 | 1 |
| ST459 | 0 | 1 | 0 | 0 | 0 | 1 |
| Total isolates tested | 31 | 1 | 29 | 2 | 1 | 64 |
Distribution of GBS isolates according to ST-type and serotype. Isolates were from asymptomatic pregnant women, IUFD cases and isolates from neonates with EOD.
EOD—early onset disease; IUFD—intrauterine fetal death